Trial intelligence / Profile preview

Metronidazole Vaginal Gel 1.3% in adolescent bacterial vaginosis

NCT02392026Phase 4Completed

Sponsor
Insud Pharma
Start
Aug 2015
Primary completion
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metronidazole in bacterial vaginosis (BV), sponsored by Insud Pharma. Started Aug 2015; status: completed.

02

Drugs

metronidazole
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on NCT02392026.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02392026.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call